Coxsackie Virus A21 Administered Intravenously (IV) for Solid Tumour Cancers (PSX-X04)

Clinical trial NCT00636558 · COMPLETED

Trial details

NCT number: NCT00636558
Sponsor: Viralytics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma Breast Cancer Prostate Cancer

Start date: 2008-02-29
Primary completion: 2012-01-12
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.